Parallax Volatility Advisers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Parallax Volatility Advisers’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-97,592	Closed	-$1.18M	–	4741
2016 Q3	$1.34M	Sell	97,592 -240,097	-71%	-$2.41M	﹤0.01%	1144
2016 Q2	$2.5M	Buy	+337,689	New	+$2.53M	﹤0.01%	858
2015 Q1	–	Sell	-14,971	Closed	-$103K	–	6172
2014 Q4	$103K	Sell	14,971 -5,930	-28%	-$37.1K	﹤0.01%	3441
2014 Q3	$113K	Sell	20,901 -4,873	-19%	-$28.5K	﹤0.01%	2815
2014 Q2	$164K	Sell	25,774 -3,908	-13%	-$26.9K	﹤0.01%	2144
2014 Q1	$239K	Buy	+29,682	New	+$231K	﹤0.01%	1364

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Parallax Volatility Advisers's ARIA Position: Q4 2016 in Review

Parallax Volatility Advisers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2016, closing a stake of 97,592 shares — an estimated $1.18M sold.

Parallax Volatility Advisers first reported a position in ARIA in Q1 2014 and held it in 6 quarters. The position peaked at $2.5M in Q2 2016. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

Parallax Volatility Advisers reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Parallax Volatility Advisers sold 97,592 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $1.18M.
Parallax Volatility Advisers first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 6 quarters.
Parallax Volatility Advisers's Ariad Pharmaceuticals Inc position peaked at $2.5M in Q2 2016.
200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on Parallax Volatility Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.